This article introduces some aspects of sports genomics in a rugby union context, considers the rugbyspecific genetic data in the published literature and outlines the next research steps required if the potential applications of genetic technology in rugby union, also identified here, are to become possible. A substantial proportion of the inter-individual variation for many traits related to rugby performance, including strength, short-term muscle power, VO 2max , injury susceptibility and the likelihood of being an elite athlete is inherited and can be investigated using molecular genetic techniques. In sports genomics, significant efforts have been made in recent years to develop large DNA biobanks of elite athletes for detailed exploration of the heritable bases of those traits. However, little effort has been devoted to the study of rugby athletes, and most of the little research that has focused on rugby was conducted with small cohorts of non-elite players. With steadily growing knowledge of the molecular mechanisms underpinning complex performance traits and the aetiology of injury, investigating sports genomics in the context of rugby is now a viable proposition and a worthwhile endeavour. The RugbyGene project we describe briefly in this article is a multiinstitutional research collaboration in rugby union that will perform molecular genetic analyses of varying complexity. Genetic tests could become useful tools for rugby practitioners in the future and provide complementary and additional information to that provided by the non-genetic tests currently used.
, yet little scientific effort has been invested to elucidate this inter-individual variation within rugby union. Rugby union athletes are qualitatively and quantitatively different from other athlete groups (both individual and team), in that there are vast difference in the physiological and anthropometric characteristics across a single rugby union team according to playing position (Smart, Hopkins, & Gill, 2013) . Rugby union is also distinctive in that individual clusters of positions require different movement patterns in elite players (Quarrie, Hopkins, Anthony, & Gill, 2012) and thus differ in their metabolic demands.
For example, anthropometric and physiological variables differ significantly across playing positions, with elite scum half players averaging ~177 cm and ~85 kg, in contrast to props averaging ~185 cm and ~117 kg -a difference of 8 cm and 32 kg (Fuller, Taylor, Brooks, & Kemp, 2013) . Furthermore, in terms of positional specific physiological differences that may be reflected in players' genetic variation, backs show lower maximal strength compared to forwards in terms of bench press (difference ~11 kg), back squat (difference ~18 kg) and power clean (difference ~9 kg; Smart et al., 2011) . However, backs are faster sprinting 10 m (difference = ~0.09 s) and 20 m (difference = ~0.11 s) than forwards (Smart, Hopkins, Quarrie, & Gill, 2011 ) and these differences become larger when specific positions are considered (Smart et al., 2013) . Positional differences are further evidenced by game demand data that shows the requirement for differing metabolic capacities dependent on playing position. Backs travel ~12% greater total distance (backs 6545 m, forwards 5850 m), achieving maximum speeds ~15% greater (forwards 26.3 km.h -1 , backs 30.4 km.h -1 ) and are engaged in two to three times more high-intensity running than forwards (Cahill, Lamb, Worsfold, Headey, & Murray, 2012; Roberts, Trewartha, Higgitt, El-Abd, & Stokes, 2008) . Furthermore, forwards perform more (~10%) high-intensity static exertion activities (rucks, mauls, scrums and line-outs) than backs (1.6%) and spend ~20% more time running faster than 80% of their maximal speed (Cahill et al., 2012; Roberts et al., 2008) (Cahill et al., 2012; Roberts et al., 2008, respectively) . The back three players (wings and fullbacks) travel the greatest distance at the lowest movement speeds (0-2 m.s -1 ) but also Quarrie et al., 2012) . These movement patterns correspond with the metabolic demands necessary to perform at the highest level in a given playing position within rugby union. The back three movement pattern suggests a requirement for a high proportion of fast twitch muscle fibres and highly developed anaerobic energy metabolism, with the front row movement pattern suggesting a greater capacity for rapid recovery between high-intensity static exertion activities. Given the highly heritable nature of these and other physical phenotypes that contribute to success in a given playing position, the differences should be reflected in distinct genetic characteristics. Furthermore, since rugby union athletes perform under a well-defined set of rules and parameters, which are ubiquitous across all playing positions, they present an ideal cohort via which to study the importance of genetic variation in sport.
In the present review, we will introduce the field of sports genomics, briefly review the current genetic research available for consideration within rugby union and outline the steps necessary to progress genomic understanding and applications in rugby union. Specifically, we will discuss some candidate genes that have been associated with physiological and anthropometric characteristics, injury risk, skill acquisition and athlete status. We will also introduce the highly collaborative RugbyGene project.
Human Genomic variation
The variation that exists in the human genome has only relatively recently be documented via progress of the Human Genome Project. Initially, ~11 million single nucleotide polymorphisms (SNP's) and 3 million short insertions and deletions were identified (Frazer et al., 2007; Sachidanandam et al., 2001; The International HapMap Consortium, 2005 (North et al., 1999) and is characterised by the replacement of the normal codon (a three bp sequence that transcribes for an amino acid (Arg; R)) by a premature termination codon (X) at the 577 amino acid position and results in the complete absence of the α-actinin-3 protein. The absence of this protein (XX genotype) is associated with a lower proportion of type 2 muscle fibres and, accordingly, is found at a lower frequency in elite power/sprint athletes compared to other athletes and non-athletes (Eynon et al., 2013) .
Physiological and anthropometric characteristics
Classical genetics is the process of estimating the heritability of a given trait and is investigated by studying families, identical twins (monozygotic; MZ) and fraternal twins (dizygotic; DZ). A number of physiological variables have been investigated in this way and are usually the preceding step to investigating specific target genes for further analysis. For example, Simoneau and Bouchard (1995) showed the genetic heritability of muscle fibre type proportion was ~50% when investigating 58 DZ and 35 MZ twin pairs. Furthermore, following 20 weeks of endurance training in 98 two-generation families (total n = 481), the heritable component of the ability to adapt, specifically an increase VO 2max , was ~50% in the well-known HERITAGE family study (Bouchard et al., 1999) . While these heritability estimates are substantial, other anthropometric phenotypes are estimated to be even greater: for example BMI at ~60%, height at ~80% (Silventoinen, Magnusson, Tynelius, Kaprio, & Rasmussen, 2008) and mesomorphy ~80% (Peeters et al., 2007) .
Subsequently, molecular genetic technologies have been applied to examine the specific genes and their variations that might explain the heritable component of these and other phenotypes. For example, two intronic SNPs in the TRHR gene (rs7832552 and rs16892496) collectively account for ~5 kg of the variability in lean body mass (Liu et al., 2009 ). The TRHR gene encodes for the thyrotrophin-releasing hormone receptor that when bound to thyrotrophin-releasing hormone, results in a signalling cascade which leads to the release of thyroxin, an important component in the development of mammalian skeletal muscle. This gene variant, especially in combination with many others, could help explain a notable proportion of the ~80% heritability of mesomorphy mentioned previously and could be applied to the assessment of rugby players. Similarly, with regards to VO 2max , 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58 Bouchard et al. (2011) found the PRDM1 gene accounted for ~7% of the inter-individual variability in adaptation to endurance training. The protein encoded by PRDM1 is widely expressed and has been implicated in skeletal muscle fibre type differentiation (Beermann, Ardelt, Girgenrath, & Miller, 2010) . The biology explaining why this gene variant is associated with VO 2max has yet to be elucidated but, again in combination with other variants such as those identified by Bouchard et al. (2011) , could provide a useful tool in rugby.
Additionally, the ACTN3 R577X gene variant (already mentioned) could, when combined with other genetic variants, be a molecular marker for muscle fibre type proportion. Vincent et al. (2007) showed that the RR genotype (presence of the protein) had ~5% greater type IIx fibres than XX genotype individuals (absence of the protein) and had ~5% larger relative surface area per fibre type (n = 43).
Supporting evidence followed using a larger sample (n = 94) where the XX genotype was associated with ~3% greater type I muscle fibre type proportion than RR individuals (Ahmetov et al., 2011) .
Injury risk
Possibly the most useful application of predictive genetics within sports genomics will be in the field of injury risk and severity estimation. Hakim et al. (2003) examined frozen shoulder (FS) and tennis elbow (TE) in 865 MZ and 963 DZ twin pairs and reported 42% heritability for FS and 40% for TE.
Additionally, while we are not aware of heritability estimates for mild-to-moderate traumatic brain injury (TBI) such as concussion, the likelihood of suffering more severe future neurological disorders following these injuries is significant (Goldman et al., 2006) .
Probably the most explored gene regarding tendon and ligament injuries is COL5A1, which encodes for the α1 chain of type V collagen, a minor fibrillar collagen (Hildebrand, Frank, & Hart, 2004) . Mokone et al. (2006) investigated the difference in genotype frequency in South African Caucasians between 111 patients with Achilles tendon pathology and 129 control subjects. They showed that the CC genotype was over-represented in the control population, suggesting a protective role of the C allele against tendon injury. A similar association, indicated a protective C allele, has been shown with cruciate ligament injuries in South African women (Posthumus et al., 2009 COL5A1 genetic marker, in combination with other markers yet to be identified, might provide a useful tool in rugby for individualising training load and mode to reduce incidence of injury.
The APOE gene is on chromosome 19 and encodes apolipoprotein E-based peptide (ApoE), a candidate marker for risk and severity of traumatic brain injury. ApoE is a protein that plays a pivotal role in cholesterol metabolism and has been linked to neurobiological function and, specifically, susceptibility to late-onset and sporadic Alzheimer's disease via APOE gene polymorphisms (Bu, 2009 ). The APOE E4 allele has also been associated with neurodegenerative cascade subsequent to TBI and the severity of axonal injury in mouse models (Bennett et al., 2013) , with human studies showing an association between the APOE E4 allele and poor outcome following TBI (Laskowitz & Vitek, 2007) . Functionally, carriers of the APOE E4 allele have presented with reduced motor rehabilitation outcomes, poorer neurocognitive outcomes, increased cognitive impairments and memory defects following TBI (Reviewed in, Gokhale & Laskowitz, 2013) . This genetic marker, combined with others such as TNFA -308, a promoter region within GRIN2A, and others including more yet to be identified, could improve estimation of both recovery duration from TBI/concussion in rugby and the risk of longer-term neurocongnitive problems -potentially useful from both short-term player management and long-term player health perspectives. The most interesting, but preliminary, 
Skill acquisition and cognitive ability
In a large study of 11,000 twin pairs from four countries (US, AUS, UK and The Netherlands), the heritability of general cognitive ability was found to increase linearly from childhood (41%) to adulthood (66%; Haworth et al., 2010) , while the ability to learn motor skills is also highly heritable at ~70% (Fox, Hershberger, & Bouchard, 1996) . One candidate to explain some of this heritability is the BDNF gene, which encodes for brain-derived neurotrophic factor, a protein that influences cortical synaptic plasticity (Akaneya, Tsumoto, Kinoshita, & Hatanaka, 1997 (Kleim et al., 2006) . Furthermore, carriers of the Met allele showed no change in neurological excitability from transcranial magnetic stimulation (TMS), whereas carriers of the Val allele showed a 67% increase (Missitzi et al., 2011) . These data suggest that carriers of the Met allele might show lower adaptation to motor learning through a lack of neurobiological excitability, possibly related to altered cortical synaptic plasticity. Another candidate is the Val158Met polymorphism in the catechol-O-methyl transferase (COMT) gene that encodes the COMT enzyme which is a major catabolising enzyme of the dopamine pathway. Individuals homozygous for the Met allele show impaired inhibition of prepotent responses (i.e. the ability to supress automated behavioural responses) and reduced working memory plasticity (Bellander et al., 2014) . It would be fascinating to test the hypothesis that favourable alleles of these BDNF and COMT gene variations, and others related to neurobiological function, may be found more frequently in playing positions with greater requirement to execute relatively fine motor skills and greater responsibility for making tactical decisions in rugby such as the half backs. Genetic tests for skill acquisition and cognitive ability might then become useful additions to other non-genetic assessments in talent identification and individualisation of skill and tactical elements of training programmes. De Moor et al. (2007) investigated the genetic component of athlete status in female 1,000 DZ and 793 MZ twins and reported a heritability estimate of ~70% for athlete status. We are not aware of similar data for males. In a review published in 2012, at least 79 genetic markers were identified that had been associated, in at least one prior research paper, with elite athlete status (Ahmetov & Fedotovskaya, 2012) . However, that number was reduced to 20 when the criterion was at least two prior research papers, and probably even some of those associations will not prove to be true as more data are accumulated. The first scientific investigation to assess the molecular genetic component of elite athlete status (Gayagay et al., 1998) showed a significant association of the ACE I/D variant (mentioned previously) with elite status in 64 rowers. Subsequently, the ACE I allele has been associated with elite performance in a variety of sports, though not consistently, and the research is probably best summarised by reference to the meta-analysis of Ma et al. (2013) For the ACTN3 R577X variant already mentioned, the R allele has been consistently associated with elite power and sprint athletes from a variety of backgrounds and in top elite sprinters, a complete absence of the XX genotype has been identified (Niemi & Majamaa, 2005; Yang et al., 2003) , compared to an XX genotype frequency of ~18% in the general Caucasian population. Again, the meta-analysis by Ma et al. (2013) nicely summarises the association of the R allele with elite power athlete status (odds ratio 1.21).
Athlete status
Gradually, a number of athlete cohorts have emerged, hosting steadily larger samples of elite and subelite athletes from various sports for the investigation of athlete status (Pitsiladis et al., 2013) . We are also aware that a UK athlete cohort is being established. One potential application of knowledge about the genetic characteristics of elite athletes, including in rugby union, could be an enhancement to talent identification programmes that are in some cases already quite sophisticated.
Genetics and rugby union
As early as 1922 scientists were hypothesising about the role of heritability in rugby union athletes. Jack (1922) documented the playing positions in 23 sets of elite rugby-playing brothers (n = 63), including a number of international representatives, and concluded that "the ability required for playing in certain positions in rugby football is inherited". We are aware of only three full publications in peer-reviewed journals applying molecular genetics to rugby union. Goh et al. (2009) reported that the II ACE genotype was associated with a higher ventilatory threshold in non-elite Asian rugby players but the very small cohort (n = 17) is a major limitation to that study. Bell et al.
recently assessed ACE I/D and ACTN3 R577X genotypes in 68 and 102 young non-elite rugby union players, respectively (Bell, Colley, Evans, Darlington, & Cooper, 2012; Bell et al., 2010) . No associations were identified between either polymorphism and athlete status, playing position or the physiological and anthropometric parameters assessed, perhaps due to the rather small sample size and the sub-elite status of the players. With such little data regarding the genetic characteristics of 
Next steps for rugby genomics research Cohort
For sports genomics research to be truly relevant to the preparation and management of elite competitors, the athletes from which the initial data are derived must themselves be considered elite.
In the context of rugby union, we propose a definition of 'elite' as athletes competing in the highest competitive league of a 'Tier 1' rugby nation. Comparisons between sub-elite (e.g. the next tier in the league structure), suitably matched controls and elite athletes would also be useful for explanatory purposes. Given the evolving nature of elite rugby, the era in which athletes competed at an elite level also needs to be defined. Rugby union has changed dramatically in the >100 years of its existence and that change has certainly continued even since the sport turned professional ~20 years ago.
Nevertheless, we propose that 1995 onwards is a playing era inclusion criterion that can sensibly be justified.
Another critical characteristic of the cohort is that it is large in number. Genetic research requires a large sample size to obtain sufficient statistical power and simultaneously minimise the likelihood of type 1 statistical error (false positive associations). Only by using a large cohort can patterns and associations in the data be identified reliably and sound conclusions made regarding associations of genetic variations within a given cohort. Consequently, large numbers (many hundreds, and preferably thousands) of 'Tier 1' rugby athletes are required -and that will only be achieved through international research collaboration. Additionally, geographic ancestry is an important consideration for case-control and genotype-phenotype association study designs and therefore analysis of molecular genetic markers should preferably be performed on athletes from a well-defined geographic ancestry cluster. A more difficult aim to achieve would be to recruit large numbers of players from all geographic ancestry clusters commonly found in rugby union, although this would be a very powerful approach scientifically. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Genotype-phenotype associations that should be investigated Following the recruitment of the appropriate cohort, the next step would be to investigate genotype associations with a range of phenotypes such as success in rugby (elite athlete status and playing position), physiological, anthropometric and other performance variables, incidence of injury, etc. We recently presented preliminary results involving 272 elite (as defined above) rugby union athletes (compared to 141 controls matched for geographic ancestry) at a scientific conference, focussing on elite athlete status in that report. Specifically, we reported an association between the ACTN3 R577X gene variant and elite rugby union athlete status as well as playing position (Heffernan et al., 2014) .
We are continuing to build this cohort in what we have termed the RugbyGene project.
Identifying genetic associations (in a cohort of elite rugby athletes) with rugby-specific physiological and anthropometric variables for example those aspects of strength, speed and body composition assessed by Smart et al. (2013) , would further exemplify the importance of the genetic component to rugby. Furthermore, rugby union has one of the highest reported incidents of match play injuries in all professional team sports (Brooks & Kemp, 2008) , with an injury incidence of 81 per 1000 match play hours resulting in ~20 days absence per injury (Williams, Trewartha, Kemp, & Stokes, 2013) .
Research collaborations that combine these kinds of large, meticulously-collected rugby injury databases with genetic analyses conducted on those very same players, could be extremely fruitful in explaining some of the as yet unexplained inter-individual variability in injury susceptibility and could identify novel markers of injury risk in rugby.
Concussion risk in rugby, as well as consideration of the potential longer-term consequences, is clearly and justifiably a topic of much attention at this time (Raftery, 2014) . Accordingly, Gardner et al. (2014) recently conducted a comprehensive meta-analysis showing that in men's rugby union, the incidence rate of concussion was ~4.7 per 1000 match play hours. Data from 16 studies showed that at the elite/international level the incidence rate was lower (~1.2 per 1000 match play hours), though still considerable (Gardner et al., 2014) . These notable injury rates make research efforts to identify molecular markers for the risk of specific rugby-related injuries, such as concussion, highly warranted. Indeed, the development of tools to identify individuals at greater risk of concussion in 
Advanced genomics technology
For rugby union as in other areas within sports genomics, the starting point for the investigation of genetic variation is through the candidate gene (hypothesis driven) approach including the genes mentioned here in this manuscript and many others. This approach is the process of considering the biological mechanisms of a given trait (for example, incidence of tendinopathy or high VO 2max ) and investigating previously identified genetic variants within genes known or suspected to affect the relevant biological pathways in some way. While the candidate gene approach is by far the most utilised technique in quantifying molecular genetic markers of sport-related phenotypes and a good starting point, other more complex analysis techniques are required for this field to realise its full potential (Pitsiladis et al., 2013) .
The hypothesis-free approach of conducting genome wide association studies (GWAS) has been utilised extensively to identify new genetic variants in various domains within human biology (Wolfarth et al., 2014) and is recommended for identifying novel genetic variants in rugby union.
GWAS is the process of investigating large numbers of known SNP's simultaneously (~2 million, for example) for a given complex trait (Visscher, Brown, McCarthy, & Yang, 2012) . As already mentioned, complex traits of relevance to rugby union could be sprinting ability, muscle strength, incidence of tendinopathy or simply being an elite rugby union player (elite athlete status).
Importantly, given the large number of hypotheses tested statistically, only the strongest associations are usually accepted to be true results (e.g. when P < 5 x 10 -8 ), although a very large cohort size and/or strong genetic effect sizes are usually required for this approach to be effective. A strength of any hypothesis-free approach like GWAS is that new variants which reveal new biological insight can be discovered -and then further investigated experimentally.
Genetic testing technologies have advanced to such an extent that investigating all nucleotides in a gene, all protein-coding genes, or even the whole genome is now possible via direct sequencing.
Depending on the availability of funding, participants and other resources including laboratory Following the identification of novel gene variations through the methods described above, simple mathematical models can be applied to simultaneously quantify the effect of several gene variants. Williams and Folland (2008) developed the total genotype score (TGS) as a way to represent the simultaneous influence of multiple genetic markers as a simple value that is intuitively understandable. According to the TGS, all scores lie between 0-100 and a higher score indicates a greater genetic suitability for a given phenotype such as muscle mass, sprinting speed, reduced injury risk, greater cognitive ability -depending on the genetic variants that are used to calculate the specific TGS in each case. Thus, multiple TGS scores, each directed towards a given phenotype, could be calculated for each individual. Subsequently, both hypothetical (Hughes, Day, Ahmetov, & Williams, 2011) and experimental (Eynon, Ruiz, Meckel, Morán, & Lucia, 2011; Ruiz et al., 2010; Ruiz et al., 2009; Santiago et al., 2010) studies have used this method in attempts to elucidate the 'optimal polygenetic profile' for a given cohort with some limited success. Other statistical methods to capture the simultaneous influence of multiple genetic markers include construction of inferred pseudo- 
Conclusion
To generate useful knowledge about the genomics of rugby union, hundreds or thousands of individual players are required in a research cohort for one to be confident that the data are robustparticularly when performing some of the more complex genomic analyses outlined in the preceding section. We and others are collaborating in a large, multi-institutional effort to make progress in this field -the RugbyGene project. There will need to be a simultaneous analysis of genomic and phenotypic (performance and injury) data to maximise the potential of this kind of research. The challenge will then be to apply genomic technologies, alongside existing non-genomic data of course, to personalise the management of players in elite rugby union and facilitate the prescription of training, nutrition, playing load and management of injury risk in a more individualised manner than is currently possible to improve both performance and player welfare. 
